Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |